International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies
dc.contributor.author | Bolon, Brad | |
dc.contributor.author | Barale-Thomas, Erio | |
dc.contributor.author | Bradley, Alys | |
dc.contributor.author | Ettlin, Robert A. | |
dc.contributor.author | Franchi, Carla Adriene da Silva [UNESP] | |
dc.contributor.author | George, Catherine | |
dc.contributor.author | Giusti, Anna Maria | |
dc.contributor.author | Hall, Robert | |
dc.contributor.author | Jacobsen, Matthew | |
dc.contributor.author | Konishi, Yoichi | |
dc.contributor.author | Ledieu, David | |
dc.contributor.author | Morton, Daniel | |
dc.contributor.author | Park, Jae-Hak | |
dc.contributor.author | Scudamore, Cheryl L. | |
dc.contributor.author | Tsuda, Hiroyuki | |
dc.contributor.author | Vijayasarathi, S. K. | |
dc.contributor.author | Wijnands, Marcel V. W. | |
dc.contributor.institution | GEMpath Inc | |
dc.contributor.institution | Charles River Labs | |
dc.contributor.institution | Ettlin Consulting Ltd | |
dc.contributor.institution | Universidade Estadual Paulista (Unesp) | |
dc.contributor.institution | Ipsen | |
dc.contributor.institution | Accelera | |
dc.contributor.institution | Covance Labs | |
dc.contributor.institution | AstraZeneca | |
dc.contributor.institution | Novartis Pharma AG | |
dc.contributor.institution | Pfizer | |
dc.contributor.institution | Seoul Natl Univ | |
dc.contributor.institution | Univ London Royal Vet Coll | |
dc.contributor.institution | Nagoya City Univ | |
dc.contributor.institution | Advinus Therapeut Pvt Ltd | |
dc.contributor.institution | Merck Sharp & Dohme Ltd | |
dc.contributor.institution | Johnson & Johnson PRD | |
dc.date.accessioned | 2014-05-20T15:30:33Z | |
dc.date.available | 2014-05-20T15:30:33Z | |
dc.date.issued | 2011-01-01 | |
dc.description.abstract | The International Federation of Societies of Toxicologic Pathologists (IFSTP) proposes a common global framework for training future toxicologic pathologists who will support regulatory-type - nonclinical toxicology studies. Trainees optimally should undertake a scientific curriculum of at least 5 years at an accredited institution leading to a clinical degree (veterinary medicine or medicine). Trainees should then obtain 4 or more years of intensive pathology practice during a residency and/or on-the-job "apprenticeship," at least 2 years of which must be focused on regulatory-type toxicologic pathology topics. Possession of a recognized pathology qualification (i.e., certification) is highly recommended. A nonclinical pathway (e.g., a graduate degree in medical biology or pathology) may be possible if medically trained pathologists are scarce, but this option is not optimal. Regular, lifelong continuing education (peer review of nonclinical studies, professional meetings, reading, short courses) will be necessary to maintain and enhance one's understanding of current toxicologic pathology knowledge, skills, and tools. This framework should provide a rigorous yet flexible way to reliably train future toxicologic pathologists to generate, interpret, integrate, and communicate data in regulatory-type, nonclinical toxicology studies. (C) 2010 Reprinted by Permission of SAGE Publications Inc. Published by Elsevier GmbH. All rights reserved. | en |
dc.description.affiliation | GEMpath Inc, Longmont, CO USA | |
dc.description.affiliation | Charles River Labs, Edinburgh, Midlothian, Scotland | |
dc.description.affiliation | Ettlin Consulting Ltd, Muenchenstein, Switzerland | |
dc.description.affiliation | Univ Estadual Paulista, UNESP, Paulista, Brazil | |
dc.description.affiliation | Ipsen, Les Ulis, France | |
dc.description.affiliation | Accelera, Nerviano, Italy | |
dc.description.affiliation | Covance Labs, Madison, WI USA | |
dc.description.affiliation | AstraZeneca, Macclesfield, Cheshire, England | |
dc.description.affiliation | Novartis Pharma AG, Basel, Switzerland | |
dc.description.affiliation | Pfizer, Groton, CT USA | |
dc.description.affiliation | Seoul Natl Univ, Seoul, South Korea | |
dc.description.affiliation | Univ London Royal Vet Coll, Hatfield, Herts, England | |
dc.description.affiliation | Nagoya City Univ, Grad Sch Med Sci, Nagoya, Aichi, Japan | |
dc.description.affiliation | Advinus Therapeut Pvt Ltd, Bangalore, Karnataka, India | |
dc.description.affiliation | Merck Sharp & Dohme Ltd, Oss, Netherlands | |
dc.description.affiliation | Johnson & Johnson PRD, Beerse, Belgium | |
dc.description.affiliationUnesp | Univ Estadual Paulista, UNESP, Paulista, Brazil | |
dc.format.extent | 187-195 | |
dc.identifier | http://dx.doi.org/10.1016/j.etp.2010.07.006 | |
dc.identifier.citation | Experimental and Toxicologic Pathology. Jena: Elsevier Gmbh, Urban & Fischer Verlag, v. 63, n. 1-2, p. 187-195, 2011. | |
dc.identifier.doi | 10.1016/j.etp.2010.07.006 | |
dc.identifier.issn | 0940-2993 | |
dc.identifier.uri | http://hdl.handle.net/11449/39901 | |
dc.identifier.wos | WOS:000286779300027 | |
dc.language.iso | eng | |
dc.publisher | Elsevier Gmbh, Urban & Fischer Verlag | |
dc.relation.ispartof | Experimental and Toxicologic Pathology | |
dc.relation.ispartofjcr | 2.023 | |
dc.relation.ispartofsjr | 0,551 | |
dc.rights.accessRights | Acesso restrito | |
dc.source | Web of Science | |
dc.subject | Toxicologic pathologists | en |
dc.subject | Education | en |
dc.subject | Training | en |
dc.subject | Experience | en |
dc.subject | Registration | en |
dc.subject | Accreditation | en |
dc.subject | Recognition | en |
dc.title | International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies | en |
dc.type | Artigo | |
dcterms.license | http://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy | |
dcterms.rightsHolder | Elsevier Gmbh, Urban & Fischer Verlag | |
dspace.entity.type | Publication | |
unesp.author.lattes | 9163387140787963[5] | |
unesp.author.orcid | 0000-0002-2830-2540[5] | |
unesp.campus | Universidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatu | pt |
unesp.department | Patologia - FMB | pt |
Arquivos
Licença do pacote
1 - 2 de 2
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição:
Carregando...
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: